Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure.
ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.
The global Fludeoxyglucose (18F) Radionuclide Injection market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fludeoxyglucose (18F) Radionuclide Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fludeoxyglucose (18F) Radionuclide Injection market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fludeoxyglucose (18F) Radionuclide Injection in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fludeoxyglucose (18F) Radionuclide Injection manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Zevacor Pharma
Queen's PET Imaging
Triad Isotopes
NCM USA Bronx
Spectron MRC
Petnet Solutions
Shertech Laboratories
Precision Nuclear
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Cancer
Coronary Artery Disease
Others
Segment by Application
Hospitals
Clinics
Diagnostics Center
Table of Contents
Executive Summary
1 Industry Overview of Fludeoxyglucose (18F) Radionuclide Injection
1.1 Definition of Fludeoxyglucose (18F) Radionuclide Injection
1.2 Fludeoxyglucose (18F) Radionuclide Injection Segment by Type
1.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cancer
1.2.3 Coronary Artery Disease
1.2.4 Others
1.3 Fludeoxyglucose (18F) Radionuclide Injection Segment by Applications
1.3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostics Center
1.4 Global Fludeoxyglucose (18F) Radionuclide Injection Overall Market
1.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue (2014-2025)
1.4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production (2014-2025)
1.4.3 North America Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
1.4.4 Europe Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
1.4.5 China Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
1.4.6 Japan Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
1.4.7 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
1.4.8 India Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Fludeoxyglucose (18F) Radionuclide Injection
2.3 Manufacturing Process Analysis of Fludeoxyglucose (18F) Radionuclide Injection
2.4 Industry Chain Structure of Fludeoxyglucose (18F) Radionuclide Injection
3 Development and Manufacturing Plants Analysis of Fludeoxyglucose (18F) Radionuclide Injection
3.1 Capacity and Commercial Production Date
3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Fludeoxyglucose (18F) Radionuclide Injection
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Fludeoxyglucose (18F) Radionuclide Injection Production and Capacity Analysis
Summary: Get latest Market Research Reports on Fludeoxyglucose (18F) Radionuclide Injection. Industry analysis & Market Report on Fludeoxyglucose (18F) Radionuclide Injection is a syndicated market report, published as Global Fludeoxyglucose (18F) Radionuclide Injection Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Fludeoxyglucose (18F) Radionuclide Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.